CPi Global CRO Welcomes Pioneer Research Solutions as a New Preferred Site Partner

Share Article

Pioneer Research Solutions has joined CPi Global CRO's preferred site network to facilitate successful clinical trials.

CPi Global CRO(CPi) announced today it has added Pioneer Research Solutions as a Preferred Site Partner. Pioneer Research has an established consortium of Physicians and KOLs in not only the United States; but also, India and Pakistan. As a preferred partner, Pioneer will partner with CPi Global in the conduct of clinical trials in a variety of therapeutic areas including Oncology, Nephrology, Endocrinology, Dermatology and Rare Diseases.

“Engaging community physicians in clinical research is important to both patients and healthcare professionals”, said CPi Global COO Eric Richardson. “Pioneer Research’s consortium of sites represent a great network of physicians and patients.”

“We are excited to be working with CPi Global as a Preferred Site Partner” said Pioneer Research Solutions, CEO & President Dr. Fahad Naveed; he further added that “CPi Global’s approach of providing personalized clinical trial management service ties in perfectly with our key service of connecting the right Investigators with the appropriate research opportunities to facilitate successful trials.”

About Pioneer Research Solutions
Pioneer Research Solutions is a leading global clinical trials management company that assists community physicians and teaching institutions/hospitals by leveraging existing relationships with pharmaceutical companies to participate in global clinical trials and provide the highest quality patient care and access to novel treatments. For more information, visit http://www.pioneerresearchsolutions.com

About CPi Global CRO
CPi Global CRO was founded in 1999 by medical professionals with the intention of providing outstanding clinical research services to the pharmaceutical and device industries. CPi is a full-service CRO managing clinical trials across Therapeutic areas and in Rare Disease. CPi’s purpose is to do their part to ensure drugs and treatments that can truly make a difference are given the best chance to do so. For more information, visit http://www.cpiglobalcro.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lee King
+1 (910) 200-5235
Email >
since: 06/2012
Follow >
Visit website